Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemay007 in Active Ulcerative Colitis
CTR20182150Phase 2Terminated
- Sponsor
- Xiajiang Hemei Pharmaceutical
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hemay007 in autoimmune colitis, sponsored by Xiajiang Hemei Pharmaceutical. Started Feb 2019; status: terminated.
02
Drugs
hemay007
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20182150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182150.